CN110650954B - 抗癌化合物 - Google Patents

抗癌化合物 Download PDF

Info

Publication number
CN110650954B
CN110650954B CN201880018986.1A CN201880018986A CN110650954B CN 110650954 B CN110650954 B CN 110650954B CN 201880018986 A CN201880018986 A CN 201880018986A CN 110650954 B CN110650954 B CN 110650954B
Authority
CN
China
Prior art keywords
unsubstituted
hydrogen
substituted
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201880018986.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN110650954A (zh
Inventor
利布拉达·玛丽亚·卡涅多赫南德斯
费尔南多·德拉卡列韦尔杜
玛丽亚·皮拉尔·罗德里格斯拉莫斯
玛丽亚·德尔·卡门·施勒伊斯纳桑切斯
帕兹·苏尼加吉龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Publication of CN110650954A publication Critical patent/CN110650954A/zh
Application granted granted Critical
Publication of CN110650954B publication Critical patent/CN110650954B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38Pseudomonas
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201880018986.1A 2017-03-17 2018-03-16 抗癌化合物 Expired - Fee Related CN110650954B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382140.6 2017-03-17
EP17382140 2017-03-17
PCT/EP2018/056665 WO2018167270A1 (en) 2017-03-17 2018-03-16 Anticancer compounds

Publications (2)

Publication Number Publication Date
CN110650954A CN110650954A (zh) 2020-01-03
CN110650954B true CN110650954B (zh) 2023-11-03

Family

ID=58398130

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880018986.1A Expired - Fee Related CN110650954B (zh) 2017-03-17 2018-03-16 抗癌化合物

Country Status (17)

Country Link
US (1) US20210317490A1 (https=)
EP (1) EP3596068A1 (https=)
JP (1) JP7209633B2 (https=)
KR (1) KR102547649B1 (https=)
CN (1) CN110650954B (https=)
AU (2) AU2018235140B2 (https=)
BR (1) BR112019019301A2 (https=)
CA (1) CA3056725A1 (https=)
CL (2) CL2019002661A1 (https=)
IL (2) IL292572A (https=)
MA (1) MA49880A (https=)
MX (2) MX392144B (https=)
MY (2) MY202630A (https=)
SG (1) SG11201908267XA (https=)
UA (1) UA126338C2 (https=)
WO (1) WO2018167270A1 (https=)
ZA (2) ZA201906518B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12156523B2 (en) 2017-03-17 2024-12-03 Mmag Co., Ltd. Plant disease control agent
CN114615999B (zh) * 2019-09-05 2024-03-08 法马马有限公司 药物抗体偶联物
CN112661808B (zh) * 2020-12-23 2022-05-27 浙江大学 一种酯肽类化合物及其制备方法和应用
EP4326869A4 (en) * 2021-04-20 2025-12-10 Univ Of Louisville RECOMBINATING MICRO-NECK

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044186A2 (en) * 2001-11-22 2003-05-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel gene cluster of pederin biosynthesis genes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2040338T3 (es) 1987-04-29 1993-10-16 Harbor Branch Oceanographic Institution, Inc. Compuestos antitumorales y antiviricos de origen marino.
US4801606A (en) 1987-07-17 1989-01-31 Harbor Branch Oceanographic Institution Inc. Antiviral compositions
WO2013016120A1 (en) 2011-07-22 2013-01-31 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Pederin and psymberin agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044186A2 (en) * 2001-11-22 2003-05-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel gene cluster of pederin biosynthesis genes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Labrenzia sp.strain PHM005 16S ribosomal RNA gene. partial sequence.;Schleissner,C. 等;《EMBL》;20161117;KX661380 *
R.Narquizian 等.The pederin family of antitumor agents:structures,synthesis and biological activity.《The Role of Natural Products in Drug Discovery》.2000,第25-56页. *

Also Published As

Publication number Publication date
KR20190129950A (ko) 2019-11-20
MX2019010890A (es) 2019-12-19
IL269353B (en) 2022-06-01
AU2018235140B2 (en) 2021-11-11
CL2019002661A1 (es) 2019-12-27
JP2020510065A (ja) 2020-04-02
CA3056725A1 (en) 2018-09-20
IL269353A (en) 2019-11-28
WO2018167270A1 (en) 2018-09-20
RU2019132808A3 (https=) 2021-10-04
AU2021277683A1 (en) 2021-12-23
JP7209633B2 (ja) 2023-01-20
IL292572A (en) 2022-06-01
CN110650954A (zh) 2020-01-03
US20210317490A1 (en) 2021-10-14
AU2018235140A1 (en) 2019-10-03
AU2021277683B2 (en) 2023-03-09
MX2021011385A (es) 2021-10-13
MX392144B (es) 2025-03-21
CL2021000117A1 (es) 2021-07-30
MA49880A (fr) 2020-06-24
MY202630A (en) 2024-05-10
EP3596068A1 (en) 2020-01-22
KR102547649B1 (ko) 2023-06-23
UA126338C2 (uk) 2022-09-21
MY195435A (en) 2023-01-20
RU2019132808A (ru) 2021-04-19
ZA201906518B (en) 2021-01-27
SG11201908267XA (en) 2019-10-30
BR112019019301A2 (pt) 2020-04-28
ZA202006147B (en) 2023-03-29

Similar Documents

Publication Publication Date Title
AU2021277683B2 (en) Anticancer Compounds
Coulup et al. Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics
Rukachaisirikul et al. Metabolites from the endophytic fungus Phomopsis sp. PSU-D15
Elissawy et al. Spiroarthrinols a and B, two novel meroterpenoids isolated from the sponge-derived fungus Arthrinium sp
Wang et al. Frenolicins C–G, pyranonaphthoquinones from Streptomyces sp. RM-4-15
Phainuphong et al. γ-Butenolide and furanone derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178
Chen et al. Stereochemical determination of new cytochalasans from the plant endophytic fungus Trichoderma gamsii
US20110136753A1 (en) Glycosylated indolecarbazoles, method for obtaining same and uses thereof
Smetanina et al. Oxirapentyns B–D produced by a marine sediment-derived fungus Isaria felina (DC.) Fr
Shu et al. Bioactive cytochalasans from the fungus Arthrinium arundinis DJ-13
Boonsnongcheep et al. Diversity of endophytic actinomycetes isolated from roots and root nodules of Pueraria candollei Grah. ex Benth. and the analyses of their secondary metabolites
Li et al. Cytosporinols AC, new caryophyllene sesquiterpenoids from Cytospora sp.
Nam et al. Isolation and characterization of actinoramides A–C, highly modified peptides from a marine Streptomyces sp.
Zhou et al. Alkaloids from an endophytic Streptomyces sp. YIM66017
Qin et al. Bioactive metabolites from marine-derived Streptomyces sp. A68 and its Rifampicin resistant mutant strain R-M1
Wu et al. New geldanamycin analogs from Streptomyces hygroscopicus
Zhao et al. Sesquiterpenoids and an ergosterol from cultures of the fungus Daedaleopsis tricolor
Phongsopitanun et al. Marine Streptomyces chumphonensis KK1-2 T produces piericidin A1 as the major secondary metabolite.
Zhang et al. A new record of Neohelicosporium guangxiense and its secondary metabolites.
RU2773023C2 (ru) Противоопухолевые соединения
Maruna et al. Isolation, structure elucidation and biological activity of angucycline antibiotics from an epiphytic yew streptomycete
Sun et al. A novel natural product from the fermentation liquid of marine fungus Trichoderma atroviride G20-12
CN109836433B (zh) 新型LL-D49194α1类似物,及其制备方法和应用
Wang et al. A new pair of pentaketide diastereoisomers from Aspergillus melleus YIM PHI001
Tchokokam et al. Bis-alkenoic acid and amide derivatives from the coprophilous fungus Scopulariopsis cordis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20231103

CF01 Termination of patent right due to non-payment of annual fee